SUMMARY.-Three hundred and nineteen patients with primary adenocarcinoma of the ovary were studied to define those factors, many of them histopathological, which influence survival. The paper considers the stage of spread at the time of operation, the histological type of the tumour, its grade and in particular its mitotic activity, which proved a significant feature per se in assessing prognosis in ovarian cancer.
A SURVEY has been carred out on 319 patients with primary adenocarcinoma of the ovary to evaluate some of the factors which influence survival in this disease. It became apparent during the investigation that the mitotic count was of considerable prognostic significance. Other factors considered were the histological type of the tumour, the stage to which it had spread at the time of operation and its histological grade. Ford (1928) was the first person to evaluate the prognosis according to the stage of spread at the time of operation, and the first large series was published in 1932 in (Heyman, 1932 . The first paper on grading appeqred at much the same time (Taylor, 1929) , and most series since that of Pemberton (1940) have treated it as an important prognostic factor.
Although cellular atypicality, as a feature of malignancy, has been discussed frequently in relation to grading, mitotic activity has received much less attention. Barzilai (1943) reported that mitoses were "frequently seen " in the group of tumours which she called " sero-anaplastic", and Allan and Hertig (1949) used profusion of mitoses as one of the indicators of the most malignant neoplasms. But at the time when this study was undertaken, no publication had been found in which mitoses were considered as a separate feature. The only published work specifically devoted to this point was by Novak and Woodruff (1967) after the present investigation had been largely completed. It confirms that the count of mitoses per high power field is of prognostic significance in carcinoma of the ovary.
MATERIALS AND METHODS
The material for this survey came from 319 patients at four hospitals.
Hospital Years Cases The Middlesex Hospital, London 1946-62 138 The Hospital for Women, Soho Square, London 1943-62 94 The Hospital for Women, Chelsea, London 1956-61 53 The Whittington Hospital, London Criteria for selection.-Since it was decided to make this series as homogeneous as possible, patients were included only if they had a primary adenocarcinoma of the ovary. Tumours metasatic to the ovary or whose origin was doutbful were excluded, and biopsy material was acceptable only where the operation notes made it clear that the surgeon had seen a distinct ovarian mass which he believed to be the primary tumour. (The importance of strict criteria for the inclusion of biopsy material has been argued by Meigs, 1940 .) Granulosa cell tumours, theca cell tumours, arrhenoblastomas, dysgerminomas and malignant teratomas have a different behaviour and age distribution and have not been considered here.
The patients studied had all had an operation or a biopsy which they survived by at least 1 month, and all were followed up for 5 years or until they died of their disease. Four hundred and ninety-three cases were originally examined and 174 were rejected because they did not fulfil the criteria set out, or because the notes or histological material were inadequate. Inoperable tumour with spread above the pelvic brim.
The histological type of the tumour.-The tumours were typed histologically into three main groups; serous, mucinous and unclassified. Among the serous tumours have been included " mesonephromas " of the adult type and endometrioid tumours. The criteria for the diagnosis of endometrioid carcinomas have been laid down by Long and Taylor (1964) , but the reported incidence of these tumours in various series ranging from from 4-8 per cent (Malloy, Dockerty, Welch and Hunt, 1965) through 11 per cent (Schueller and Kirol, 1966), 16-7 per cent (Long and Taylor, 1964) to 24 per cent (Santesson, quoted by Long and Taylor, 1964) : confirms our experience that it is impossible to discriminate between the poorly differentiated serous and endometrioid carcinomas. The well differentiated endometrioid carcinomas, especially when they show squamous metaplasia, are readily identifiable (Fig. 1 ), but the incidence and behaviour of endometrioid carcinomas, throughout the whole range of differentiation, has proved impossible to quantitate. A recent review of " Mesonephromas " of the clear cell type or those with a characteristic tubular pattern (Scully and Barlow, 1967) has given considerable plausibility to the concept that these represent a variant of endometrioid carcinoma and their existence as a distinct entity has also been disputed by Stowe (1955) Willis (1967) . In any event other series (Parker, Dockerty and Randall, 1960; Novak and Woodruff, 1959; Czernobilsky, Silverman and Enterline, 1970) suggest that their behaviour is that of serous carcinomas.
Unclassified tumours have been included in this series. There histological appearance suggests that they are the anaplastic variants of the common serous and endometrioid, but not mucinous, carcinomas; and this belief, which is held by other workers (Taylor, 1959; Montgomery, 1948) , has even led some (e.g. Barzilai, 1943) to use the term " sero-anaplastic " to describe them.
The histological grade of the tumour.-In the histological grading of carcinoma of the ovary problems which are inherent in any system of grading arise in relation to sampling. But differences from one part of the tumour to another are not usually marked, as the detailed study of Taylor and Long (1955) demonstrated, and it is our experience that any one tumour tends to have a consistent growth pattern which is reproduced in different parts of the tumour, and to a lesser extent in metastases.
The tumours were placed in three grades, depending on their microscopic (Allan and Hertig, 1949; Kent and McKay, 1960) . But the inclusion of only " the wildly anaplastic " (Allan and Hertig, 1949) One feature which, on this system of grading, could lead to error, is the misinterpretation of solid islands of squamous epithelium in adenoacanthomas (Fig. 2) . Following the lead of others who have discussed the presence of squamous metaplasia as an indication of high grade malignancy (Pemberton, 1940; Malloy et al., 1965) , solid masses of squamous epithelium were initially regarded in this survey as a sign of a high level of malignancy, but it became clear that this was erroneous, and that the malignant potential-as in the uterine adenoacanthoma (Novak and Nally, 1957) lies in the glandular epithelium.
Mitotic activity.-The number of mitoses per high power field was counted in the most active area of each tumour (at a magnification of 420 times). In most instances an average count over at least six fields was taken. Occasionally, fewer fields had to suffice, for example in a highly necrotic tumour in which there was only a rim of viable tissue, and also in tumours in which there was only a small area of malignant change in an otherwise benign cyst.
In some tumours with an extensive fibrotic stroma, a large part of every high power field was occupied by fibrous tissue. In these cases an estimate was made of the number of mitoses there would have been in a cellular field, in order to give the same percentage of mitoses. This is the method advocated and adopted by 19 239 Bloom and Richardson (1957) A wide variation in 5-year survival figures for carcinoma of the ovary has been quoted by Munnell and Taylor (1949) , ranging from 6-3 per cent (Walter, Bachman and Harris (1941) to 65per cent Counseller (1940) . Table I summarises some recent series and shows that a 5-year survival rate of between 20 and 40 per cent is the usual finding.
There are three main reasons for variations in survival figures: differences in treatment, differences in diagnosis and differences in the selection of cases.
The claims made for different forms of treatment have been excellently reviewed by Rubin, Grise and Terry (1962) , who point out that the efficacy of radiotherapy or different forms of chemotherapy remains a matter for dispute.
The diagnosis of malignancy in ovarian tumours is often a matter of considerable difficulty, and this led Taylor (1929) to apply the term " semi-malignant " to certain serous neoplasms. In the case of mucinous tumours, as pointed out by Saxen and Hakama (1964) , assessment may be even more contentious, despite the work of Cariker and Dockerty (1954) in defining the criteria of malignancy.
Differences in diagnosis are not the only reasons for variation in survival figures. Different series are frequently compared on the unstated assumption that the patients comprise similar populations, but a brief review shows how unfounded this assumption is. Table I shows wide variations between the number of inoperable cases included in each series. (Turner et al., 1959) .
The stage of spread reached at the time of operation It is apparent that there are two outstanding groups. The 106 patients in stage IA with unilateral intracapsular lesions, and the group of 93 patients where the tumour had spread beyond the pelvis and was inoperable. The greatest differences in the stages occur between IA and IB, on the one hand, and IIIA and IIIB on the other. These correspond to the differences between unilateral tumours confined within the ovary, IA, and those which have spread to the surface of the ovary, IB, whilst the difference between stages IIIA and IIIB, represents those cases in which all macroscopically visible tumour was resected and those in which residual tumour had to be left at the time of operation.
To correspond to these divisions, the tumours were regrouped in three stages: Unilateral intracapsular tumours- 123 cases The differences in survival between these three groups at 5 years are highly significant (X2= 84, n = 2, P<0-001). They are expressed as percentages in Fig. 3 .
The theoretical advantages in using an anatomical basis for staging have been very ably argued by Van Orden and her colleagues (1966 (1965) used a measure of more than 250 ml. of ascitic fluid present at operation, but in a retrospective study dealing with cases where ascites was not always considered important at operation, such precision could not be achieved, and it was thought better to omit a matter on which no accurate assessment could be made.
A separate investigation was carried out to determine the appropriate stage of unilateral intracapsular tumours which had ruptured during removal. There were 18 patients in this group of whom 12 (two-thirds) survived 5 years. This is almost identical with the 65 per cent 5 year survival ofthe 88 women with unilateral intracapsular lesions which had not ruptured. Such a finding has been reported before (e.g. Malloy et al., 1965; Munnell et al., 1957) , but remains surprising, in view of the additional risk of dissemination of malignant cells. This is the pattern of distribution found in most series (Saxen and Hakama, 1964) , and may be taken as representative. Fifty-three out of the 68 patients with mucinous tumours survived 5 years, whereas only 49 of the 185 with serous tumours, and 12 of the 66 with unclassified tumours did so. The much greater likelihood of survival for those having mucinous tumours than for those with serous tumours is statistically highly significant (X2 = 545, n = 1, P < 0X001). On the other hand, although a smaller proportion of patients with unclassified tumours survived 5 years than did those with serous tumours, the difference is not significant (X2 -1X82, n -1, 0-2 >P >0.1). When the type of tumour is compared with the stage of spread (Table III) it becomes apparent that the majority of mucinous tumours were of an early stage, whereas there was a preponderance of inoperable tumours among the serous and unclassified types. The relative proportions of the different histological types of tumour in the three main stages are shown in Fig. 4 , which also shows the proportion who died within 5 years of operation.
Although the better survival in the mucinous group is partly explained by the greater numbers in the earlier stages of development, it may be seen that there are differences in survival within each stage between the different types of tumour. Whilst the differences between serous and unclassified tumours are small, the differences between serous and mucinous are significant for unilateral intracapsular tumours (X2 = 6'0, n = 1, P < 0.02) and for inoperable tumours (X2= 5-2, n = 1, P < 0.05), but do not reach significance in the intermediate group of operable tumours with spread beyond the ovarian capsule (X2 = 2'17, n = 1, P < 0.2).
In some ways the survival figures are more disappointing than might have been hoped, for the apparent intactness of the ovarian capsule is clearly illusory. Microscopic spread must have already occurred in nearly half the serous and in the majority of the unclassified carcinomas which at operation were thought to be unilateral and intracapsular.
Serous The differeiices in 5-year survival betweeii the three groups is highly significant (x2 = 87-2, n = 2, P < 0-000). The mitotic count and nuclear atypicality The system of grading described above depends on the pattern of the tumour seen, for the most part, under the low power of the microscope. Cellular atypicality and the frequency of mitosis, on the other hand, are features of the high power magnification. They were examined separately.
It was found on reviewing these carcinomas, that, apart from mitotic activity, the presence of nuclear atypicality is not a useful guide to the degree of malignancy. The groupings it encourages are few and there is a large indistinct borderland between the different groups. The well differentiated tumours are made up of cells with small nuclei, which are regular in shape and have inconspicuous nucleoli, and the few anaplastic tumours are composed of extremely bizarre cells with gross cellular atypia. All the tumours between these two extremes have minute gradations from the small and regular to the large reticular nucleus with a pronounced nucleolus. Accurate measurement of the size of the nucleolus, and its properties, shown by various histochemical techniques, have been discussed by Taylor and Long (1955) , and have been found in their hands to be useful indicators of malignancy. But the techniques and methods required make it impossible for such methods ever to be used routinely, and without them the accurate assignment of tumours to different groups is impossible.
Counting the number ofmitoses per high power field allows a much greater degree of precision than can be reached by considerations of atypicality. It was shown by Evans (1926) that tissues can remain unfixed for up to 24 hours without affecting the mitoses seen, so that even the interior of large malignant ovarian cysts gives a representative picture of the mitotic activity. By using such a system of counting, one can be confident of a greater degree of accuracy in assigning the tumours to four groups depending on their mitoses than into three groups based on the degree of nuclear atypicality.
Mitotic activity in ovarian carcinomas is not striking. In this study few tumours were found which had more than five mitoses per high power field, and very few had more than eight. The striking feature was the lack of mitoses even in poorly differentiated cancers. This observation was confirmed by Van Orden et al. (1966) who observed " a surprising finding was the paucity of tumours which had shown an increased number of mitoses ... Only 13 per cent had mitoses as a prominent feature " It conflicts, however, with the reports of Novak and Woodruff (1967) , which appeared after our study had been largely completed. In the former study, the only one which has given numerical expression to an appraisal of mitotic activity in ovarian carcinomas, there was agreement with our observations that the number of mitoses correlated with the patient's chance of survival. In contrast with our findings and those of Van Orden et al. (1966) , Novak and Woodruff reported a nigh number of mitoses in most tumours. It is probable that the procedure adopted was different from our method, where only cells in prophase and metaphase were counted, and, more important, where an average count of several fields in the most active area was taken. It is obviously easy to arrange a section in such a way that a particular field contains many more than the average number of mitoses for the tumour, and to count the number of of mitoses in the worst field. This would have been an alternative approach to the investigation, and probably the one adopted by Novak and Woodruff. It was found that the presence of an average of three or more mitoses per high power field (see Fig. 5 ), gave a uniformly poor prognosis: The 5-year survival figures for the patients with tumours of three or more mitoses was significantly worse than those in patients with two (X2 = 12-03, n = 1, P < 0.001). Even with two mitoses the majority of patients died, but with only one mitosis the numbers were almost evenly divided, and with an average of less than one mitosis as in Fig. 6 , almost all the patients lived. The difference in survival of patients with two mitoses and with one mitosis is highly significant (x2 = 10X2, n = 1, P < 0.01); so also is the difference between one and less than onemitosis(X2 = 154,n = 1,P < 0001).
When the mitotic count was compared with the other ways of assessing the tumours good correlations occurred.
(i) With regard to the stage reached at operation it was found that the unilateral intracapsular tumours had one, or less than one mitosis per high power field in 71 per cent of the cases. The operable tumours in stages IB to IIIA were fairly evenly spread, although with a relative lack of cases with less than one mitosis per high power field. In the highly malignant inoperable group, the majority showed three or more mitoses per high power field.
Evaluation of mitoses may also be useful in the cases of doubtful or borderline malignancy. Only two women died whose tumours had less than one mitosis per high power field, and in both cases the tumours were clinically malignant with spread.
(ii) A comparison of the mitotic count with the histological type of the tumour largely accounts for the superior survival figures of patients with mucinous carcinomas. Forty-five per cent had less than one mitosis per high power field, and only a quarter had two or more. By contrast, 43 per cent of serous, and 61 per cent of unclassified tumours had three or more mitoses per high power field. Classification by mitotic activity also explains the relatively benign behaviour of the adenoacanthoma (Fig. 2) , since all in this series had few mitoses.
(iii) There is, not surprisingly, very great interdependence between the mitotic count and the grade of the tumour. They are, after all, two ways of expressing the histological malignancy of a carcinoma. In our series it was found that there were 245 patients in Grade 1 and Grade 3, and 30 of them behaved anomalouslythat is, they died of tumours of Grade 1 or lived with tumours of Grade 3. There The other point which this staging system has emphasised is the importance of the intactness of the ovarian capsule. It is to some extent illusory, since there must have been microscopic penetration in the women with unilateral intra capsular tumours who died of carcinoma of the ovary. Nevertheless it is th( only stage which carries a better than 50 per cent chance of survival, so it ih important that women whose tumours are of this stage should be marked oul as having a better than average prognosis.
(ii) The histological type of the tumour: The discussion in this survey has beer centred on the relatively favourable mucinous carcinomas, although mention ha, also been made of those endometrioid carcinomas whose low grade is signalled by the development of squamous metaplasia. The demarcation of these tumours however, only serves to emphasise the bleak outlook for the majority of patients with ovarian carcinoma, for most tumours are serous or unclassified and they are usually highly malignant.
(iii) The histological grade of the tumour: The histological grade has been shown to be related, to a great extent, to the stage of spread, and to a lesser extent to the histological type. It is revealed as a reliable indicator of the patient's prognosis-in fact a more sensitive means of discrimination than the stage ol spread. Admittedly, the largest group of women had grade 3 tumours and only 21 per cent had grade 1 tumours, but most women with carcinoma of the ovary do die, and any attempt to balance the numbers by adopting different criteria foi the various grades would only have diminished the usefulness of the distinctions between them.
(iv) The mitotic count: There is a highly significant degree of correlation between the mitotic count and survival. It corresponds closely with the grade ol the tumour, and correlates with the stage, and to some extent with the type ol the tumour. Although patients with mucinous carcinomas do better than those with serous or unclassified tumours for all mitotic counts, when adjustments are made for the generally earlier stage of mucinous carcinomas this superiority disappears. Thus, by using the mitotic count one may assess the malignant potential of a tumour without reference to its histological type. This has obvious advantages in a field as confused as the histological typing of ovarian carcinomas is at the moment. It also evades the difficulties inherent in having a class ol unclassified tumours.
Comparison of the mitotic count with grading shows that to some extent 247 they produce similar results since they are both ways of assessing the rate of growth of a tumour. However, a third way of assessing malignancy-the degree of cellular atypicality apart from mitoses-was not found helpful in this survey.
A mitotic count has the advantage over grading that it is easy to put into practice and is readily reproducible from time to time and person to person. Furthermore, it does not need previous agreement on the criteria for different grades (a problem which, as has been shown, bedevils grading). Both grading and mitotic activity give a fairly reliable guide to the behaviour of the majority of tumours (those in grades 1 and 3, and those with less than one or more than two mitoses) but the guidance from the mitotic count has the advantage that it is surer and less liable to prove fallible. Using the count of mitoses it is possible to predict with a good degree of accuracy the likely outcome for any woman with an ovarian carcinoma.
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